The activated Janus kinase (JAK)/STAT pathway observed in most solid tumors can affect CRC development by modulating the cell growth, survival, invasion, and migration [19], and some of its antagonists impede the progression of malignancies [20]. This evidence concerns the gene SOAT1 and colorectal carcinoma.